Quick Answer
Dare Bioscience, Inc. reported Earnings Per Share Diluted of $1.20 (loss) per share for the year ending 2025.
- Dare Bioscience, Inc. showed a decrease of -150.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Dare Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Dare Bioscience, Inc.'s Earnings Per Share Diluted has declined by 31.9%.
- Historical annual values: Fiscal year 2025: $1.20 (loss) per share | Fiscal year 2024: $0.48 (loss) per share | Fiscal year 2023: $4.15 (loss) per share | Fiscal year 2022: $0.37 (loss) per share | Fiscal year 2021: $0.63 (loss) per share | Fiscal year 2020: $0.91 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: